國立高雄大學圖資館 |

Fungi bioactive metabolitesintegration of pharmaceutical applications /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Fungi bioactive metabolitesedited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena.
Reminder of title:	integration of pharmaceutical applications /
other author:	Deshmukh, Sunil Kumar.
Published:	Singapore :Springer Nature Singapore :2024.
Description:	xvii, 762 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Fungal metabolites.
Online resource:	https://doi.org/10.1007/978-981-99-5696-8
ISBN:	9789819956968$q(electronic bk.)

Fungi bioactive metabolitesintegration of pharmaceutical applications /
Fungi bioactive metabolitesintegration of pharmaceutical applications /[electronic resource] :edited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena. - Singapore :Springer Nature Singapore :2024. - xvii, 762 p. :ill., digital ;24 cm.

Part I: Bioactive Compounds from Endophytic Fungi -- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi -- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity -- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds -- Part II: Endolichenic Fungi: A Source of New Chemical Entities -- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds -- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective -- Part III: Marine Fungi as a Source of Medicinal Compounds -- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline -- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities -- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents -- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites -- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer -- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases -- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential -- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer -- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development -- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses -- Part V: Fungi from Extremophilic Environment/Unique Ecosystems -- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals -- Chapter 17. Bioactive Metabolites Produced by Fungi Present in Antarctic, Arctic and Alpine Ecosystems -- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production -- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy -- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds -- Chapter 20. Strategies for Enhancing the Production of Echinocandin -- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications -- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential -- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin -- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application -- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development -- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery? -- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects.

This book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi existing in the extremophilic conditions like desert and Antarctica and Artic environment. The book tries to cover maximally the range of the pharmaceutical applications wherein these bioactive agents from fungi have been exploited or are in the clinical pipelines and primarily include antibacterial, antifungal, antibiofilm, anticancer, antioxidant, autoimmunological, anti-inflammatory, and anti-thrombotic diseases. The book further emphasizes on the novel strategies to screen or enhance secondary metabolite production. Some other topics includes peptides, nonpeptides drugs, pigments, and enhancement of production of Echinocandin and Kojic acid. The role of bioinformatics in drug discovery and biotransformations have also been discussed. This book is going to be a comprehensive treatise and a valuable source for mycologists, biotechnologists, microbiologists, biotechnologists, and undertaking research in pharmaceutical sector as well as academia in setting up their research aspirations for using fungi in the process of drug discovery and development.

ISBN: 9789819956968$q(electronic bk.)

Standard No.: 10.1007/978-981-99-5696-8doiSubjects--Topical Terms:

502103
Fungal metabolites.

LC Class. No.: RS165.F72 / F86 2024

Dewey Class. No.: 572.829

Fungi bioactive metabolitesintegration of pharmaceutical applications /
LDR:05398nmm a2200325 a 4500 001 662620
003 DE-He213
005 20240228065805.0
006 m d
007 cr nn 008maaau
008 241203s2024 si s 0 eng d
020 $a 9789819956968$q(electronic bk.)
020 $a 9789819956951$q(paper)
024 7 $a 10.1007/978-981-99-5696-8 $2 doi
035 $a 978-981-99-5696-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RS165.F72 $b F86 2024
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 572.829 $2 23
090 $a RS165.F72 $b F981 2024
245 0 0 $a Fungi bioactive metabolites $h [electronic resource] : $b integration of pharmaceutical applications / $c edited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xvii, 762 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part I: Bioactive Compounds from Endophytic Fungi -- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi -- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity -- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds -- Part II: Endolichenic Fungi: A Source of New Chemical Entities -- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds -- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective -- Part III: Marine Fungi as a Source of Medicinal Compounds -- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline -- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities -- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents -- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites -- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer -- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases -- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential -- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer -- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development -- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses -- Part V: Fungi from Extremophilic Environment/Unique Ecosystems -- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals -- Chapter 17. Bioactive Metabolites Produced by Fungi Present in Antarctic, Arctic and Alpine Ecosystems -- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production -- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy -- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds -- Chapter 20. Strategies for Enhancing the Production of Echinocandin -- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications -- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential -- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin -- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application -- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development -- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery? -- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects.
520 $a This book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi existing in the extremophilic conditions like desert and Antarctica and Artic environment. The book tries to cover maximally the range of the pharmaceutical applications wherein these bioactive agents from fungi have been exploited or are in the clinical pipelines and primarily include antibacterial, antifungal, antibiofilm, anticancer, antioxidant, autoimmunological, anti-inflammatory, and anti-thrombotic diseases. The book further emphasizes on the novel strategies to screen or enhance secondary metabolite production. Some other topics includes peptides, nonpeptides drugs, pigments, and enhancement of production of Echinocandin and Kojic acid. The role of bioinformatics in drug discovery and biotransformations have also been discussed. This book is going to be a comprehensive treatise and a valuable source for mycologists, biotechnologists, microbiologists, biotechnologists, and undertaking research in pharmaceutical sector as well as academia in setting up their research aspirations for using fungi in the process of drug discovery and development.
650 0 $a Fungal metabolites. $3 502103
650 0 $a Fungi $x Therapeutic use. $3 797096
650 1 4 $a Biomedical Research. $3 243625
650 2 4 $a Drug Delivery. $3 911847
650 2 4 $a Molecular Biology. $3 189026
650 2 4 $a Molecular Ecology. $3 274334
650 2 4 $a Cell Biology. $3 274165
700 1 $a Deshmukh, Sunil Kumar. $3 853394
700 1 $a Takahashi, Jacqueline Aparecida. $3 974903
700 1 $a Saxena, Sanjai. $3 715414
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-5696-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)